Clinical Trial

Evaluation of Gixam's Efficacy Predicting Pre-cancerous Colorectal Polyps and Colorectal Cancer

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 14, 2024 (before its estimated March 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a prospective, single arm, multi-center clinical investigation aim to demonstrate the efficacy of Gixam in predicting the presence of premalignant colorectal polyps and colorectal cancer (CRC) in a fecal immunochemical test (FIT) positive population.
Trial Details
NCT Number NCT06688110
Lead Sponsor Jubaan Ltd.
Collaborators: Jubaan GmbH
Conditions Colorectal Cancer, Colorectal Adenomatous Polyp, Colorectal Neoplasms
Enrollment 800 participants
Start Date 2025-02
Primary Completion 2026-03 (estimated)
Study Completion 2026-04 (estimated)
Updated on ClinicalTrials.gov 2024-11-14